A 54-year-old male presented with pain in the left cheek for 2 months. Five years back, he had undergone wide local excision with left segmental mandibulectomy and lymph nodal dissection, followed by radiotherapy for carcinoma of the left buccal mucosa, which revealed adenoid cystic carcinoma (ACC) in postoperative histopathology. In view of this past history, ^18^F-fluorodeoxyglucose positron emission tomography/computed tomography (^18^F-FDG PET/CT) was performed for recurrence evaluation. Maximum-intensity projection \[[Figure 1a](#F1){ref-type="fig"}\], transaxial CT, and fused PET/CT images revealed FDG-avid lesion in the region of left retromolar trigone \[arrow; Figure [1b](#F1){ref-type="fig"} and [c](#F1){ref-type="fig"}; SUV~max~ 9.3\] and buccal mucosa, eroding the adjoining alveolar plate and involving the left lateral pterygoid muscle. Multiple FDG-avid parenchymal nodules \[arrow; Figure [1d](#F1){ref-type="fig"} and [e](#F1){ref-type="fig"}; SUV~max~ 11.6\] were also noted in bilateral lung fields.

![^18^F-fluorodeoxyglucose positron emission tomography/computed tomography maximum-intensity projection (a), transaxial computed tomography, and fused positron emission tomography/computed tomography images showing fluorodeoxyglucose-avid lesion in the region of left retromolar trigone (arrow; b and c) and buccal mucosa, eroding the adjoining alveolar plate and involving the left lateral pterygoid muscle. Multiple fluorodeoxyglucose-avid parenchymal nodules (arrow; d and e) noted in the bilateral lung fields](IJNM-34-71-g001){#F1}

With suspicion of pulmonary metastasis, the patient was scheduled for ^18^F-FDG PET/CT-guided biopsy from the parenchymal nodule in the right lung. With the patient in prone position, the nodule with the maximum FDG uptake was selected for performing needle biopsy. Transaxial \[Figure [2a](#F2){ref-type="fig"} and [b](#F2){ref-type="fig"}\] and sagittal \[Figure [2c](#F2){ref-type="fig"} and [d](#F2){ref-type="fig"}\] CT and fused PET/CT images confirmed the correct positioning of the needle. Histopathology of the biopsy specimen confirmed metastatic ACC.

![^18^F-fluorodeoxyglucose positron emission tomography/computed tomography for guided biopsy: transaxial (a and b) and sagittal (c and d) computed tomography and fused positron emission tomography/computed tomography images confirming the correct positioning of the biopsy needle](IJNM-34-71-g002){#F2}

The patient was treated with chemoradiation for 6 months and scheduled for ^18^F-FDG PET/CT, 4 months later for response evaluation. Maximum-intensity projection \[[Figure 3a](#F3){ref-type="fig"}\], transaxial CT, and fused PET/CT images revealed FDG-avid lesion in the region of left retromolar trigone \[arrow; Figure [3b](#F3){ref-type="fig"} and [c](#F3){ref-type="fig"}; SUV~max~ 9.5\] and buccal mucosa with no significant change from the previous study. Multiple FDG-avid parenchymal- and pleural-based nodules \[arrow; Figure [3d](#F3){ref-type="fig"} and [e](#F3){ref-type="fig"}; SUV~max~ 42.1\] were noted in the bilateral lung fields with increase in FDG avidity, size, and number compared to the previous study, suggesting disease progression. The patient refused further treatment and was lost to follow-up.

![^18^F-fluorodeoxyglucose positron emission tomography/computed tomography maximum-intensity projection (a), transaxial computed tomography, and fused positron emission tomography/computed tomography images showing fluorodeoxyglucose-avid lesion in the region of left retromolar trigone (arrow; b and c) and buccal mucosa. Multiple fluorodeoxyglucose-avid parenchymal- and pleural-based nodules (arrow; d and e) noted in the bilateral lung fields](IJNM-34-71-g003){#F3}

ACC is a malignant neoplasm developing more commonly in minor (\~60%) than major salivary glands (\~40%).\[[@ref1]\] The disease often has an indolent course with multiple episodes of recurrence and distant metastases, commonly to the lung and bones, as a late occurrence.\[[@ref1]\] ACCs have been typically characterized as low grade-to-non-FDG avid tumors, reported as false negative on ^18^F-FDG PET/CT.\[[@ref2][@ref3]\] Later, various reports demonstrated the role of ^18^F-FDG PET/CT in evaluating disease recurrence and identification of distant metastases in ACC, thus affecting patient management.\[[@ref4][@ref5]\] In comparison with magnetic resonance imaging, ^18^F-FDG PET/CT showed superior sensitivity for detection of local tumor recurrence and regional and distant metastases.\[[@ref6]\] Due to the inherent aggressive nature of the primary neoplasm, distant metastases in most patients is inevitable, even after being treated with curative intent, leading to poor prognosis.\[[@ref7][@ref8]\] The present case illustrates the holistic role of ^18^F-FDG PET/CT in the entire workup of the patient including identification of local tumor recurrence and distant lung metastases, in their histopathological confirmation by guided biopsy, and in assessing treatment response evaluation.
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